advancing innovation to save lives

GHTC launches petition calling on world leaders to include R&D in the Global Health Security Agenda

GHTC launched a new online petition calling on world leaders to include clear commitments to strengthening R&D capacity in the 2019-2024 Global Health Security Agenda framework, which is currently under development.
Take Action

Return On Innovation: Learn how global health R&D delivers for your state

Global health R&D matters globally and benefits you locally. Find out how US investments in global health R&D are paying economic and health dividends in your state.
View

Member Spotlight: Global Health Council

Global Health Council (GHC) is the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Katrina Peach
GHTC statement on TB high-level meeting delivered at WHA

A statement by GHTC and partners calling for the United Nations High-Level Meeting on Ending TB to issue a political declaration focused on increasing investments in tuberculosis (TB) R&D was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, Infectious Diseases Society of America, Elizabeth Glaser Pediatric AIDS Foundation, and Partners in Health, also encourages the inclusion of child-specific targets for TB R&D and additional resources for R&D to combat drug-resistant TB.

PDF
PATH/Eric Becker
GHTC statement on access to medicines delivered at WHA

A statement by GHTC and partners calling for the World Health Organization to support a comprehensive approach to addressing barriers to access to medicines was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, American Academy of Pediatrics, NCD Child, and the International Federation of Psoriasis Associations, notes the importance of strengthening regulatory systems and harmonizing processes.

PDF
View All News & Events

Community Event

PATH/Gabe Bienczycki
7th East African Health and Scientific Conference
East African Health Research Commission
Learn More

Member Event

PATH/Will Boase
International Conference on Emerging Infectious Diseases (ICEID)
Centers for Disease Control and Prevention, American Society for Tropical Medicine and Hygiene, Infectious Diseases Society of America, and other partners
Learn More
View All Events
Wanted: Tools to fight murderous mozzies and their deadly diseases

For World Mosquito Day, GHTC is taking a moment to shine a spotlight on the ghastly gang of mosquito-borne diseases and the innovations we need to finish these frightening foes for good.

Read More
PATH/Georgina Goodwin
Research Roundup: Ebola vaccinations in North Kivu, the role of biobanks in research, and a new Zika vaccine candidate

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide